Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a systematic review.
Beta blockers look promising on paper, but the evidence is too thin for clinical bets.
01Research in Context
What this study did
Ward et al. (2013) hunted every paper on beta blockers for problem behaviors in people with intellectual disability.
They screened lab studies, case reports, and tiny open trials. No true randomized controlled trials existed.
What they found
Most reports said behaviors like hitting or yelling dropped while the drug was given.
The team rated the proof quality as poor: small samples, no blinding, no placebo arms.
Bottom line: beta blockers might help, but we cannot trust the numbers yet.
How this fits with other research
Hirota et al. (2014) ran a stricter test. They pooled seven small RCTs on antiepileptic drugs for irritability in autism. The result: no benefit over placebo.
That null finding backs Frances’ warning: without RCTs, early “success” stories can mislead.
Campbell (2003) and Heyvaert et al. (2014) show the flip side. Their meta-analyses of behavioral interventions found strong, replicable cuts in problem behavior when a functional analysis guided treatment.
So we now have two parallel tracks: weak drug evidence versus robust behavior-analytic evidence.
Why it matters
If a family asks about pills, you can share that beta blockers remain experimental. Push for a functional assessment and behavior plan first. Track baseline heart rate and blood pressure before any medical trial. Keep single-subject graphs so the team can see if change really happens.
Get CEUs on This Topic — Free
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Graph the target behavior for one week, then present the data to the prescriber before any dose change.
02At a glance
03Original abstract
Both medication and non-medication based strategies are used in the management of problem behaviours in individuals with intellectual disabilities. Beta-adrenoceptor blocking medications are one group of drugs used for this purpose. However, despite its regular use, the evidence for the efficacy of these drugs for in this context is lacking. A systematic review was conducted to establish the research evidence for the efficacy of beta blockers in problem behaviours in adults and children with intellectual disabilities. Although the research identified supported the efficacy of beta blockers for this indication the overall quality of studies identified was poor and no randomised controlled trials were identified. There is a need for more robust research into the use of beta blockers for people with intellectual disabilities who show problem behaviours.
Research in developmental disabilities, 2013 · doi:10.1016/j.ridd.2013.08.015